Skip to content
lifestyle.clientim.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Lyell Immunopharma, Inc
Lyell Immunopharma to Present Phase 1/2 Safety and Translational Data for Ronde-Cel in Large B-Cell Lymphoma at the European Hematology Association 2026 Congress
June 4, 2026
Lyell Immunopharma Announces Participation in Goldman Sachs 47th Annual Global Healthcare Conference 2026
June 1, 2026
Lyell Immunopharma Announces Participation in May Investor Conferences
May 12, 2026
Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2026
May 6, 2026
Lyell Immunopharma Announces Participation in 25th Annual Needham Virtual Healthcare Conference
April 7, 2026
Lyell Immunopharma Reports Q4 and Full Year 2025 Business and Financial Results
March 12, 2026
Lyell Immunopharma Announces Closing of Additional $50 Million Tranche of Equity Private Placement and Appointment of Smital Shah as Chief Financial and Business Officer
March 9, 2026
Lyell Immunopharma Announces Participation in March Investor Conferences
February 23, 2026
Lyell Immunopharma Announces Initiation of Patient Dosing in First-of-Its-Kind Phase 3 Head-To-Head CAR T-Cell Clinical Trial in Aggressive Large B-Cell Lymphoma
February 20, 2026